ALX Oncology Holdings United States of America (USA)
Research
Date range: 1 January 2022 - 31 December 2022
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for ALX Oncology Holdings published between 1 January 2022 - 31 December 2022 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
1 | 0.07 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 1 | 0.07 |
Share output for the past 5 years
2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
0.00 | 0.00 | 0.00 | 0.00 | 0.07 |
Nature Strategy Reports
Nature Strategy Reports gives you simple insights to support decisions that impact your organisation
The reports created for you by our subject matter experts combine compelling insights with Nature’s trust and authority. Get an in-depth analysis of your and your peers’ research performance, including a breakdown of relative strengths and weaknesses. All of which is crafted using data and tools from across Nature Research Intelligence, covering all major disciplines and all regions of the world.
Collaboration
Date range: 1 January 2022 - 31 December 2022
International vs. domestic collaboration by Share
- 76.18% Domestic
- 23.82% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with ALX Oncology Holdings by Share (4 total)
-
ALX Oncology Holdings and Stanford University
(0.84)
-
ALX Oncology Holdings and University of California, San Francisco (UCSF)
(0.14)
-
ALX Oncology Holdings and Ludwig Center at Stanford
(0.11)
-
ALX Oncology Holdings and Ludwig Cancer Research
(0.09)
Top 10 international collaborators with ALX Oncology Holdings by Share (4 total)
-
ALX Oncology Holdings and Provincial Health Services Authority (PHSA)
(0.12)
-
ALX Oncology Holdings and University of Oxford
(0.09)
-
ALX Oncology Holdings and Chinese Academy of Medical Sciences Oxford Institute (CAMS Oxford Institute)
(0.08)
-
ALX Oncology Holdings and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC)
(0.08)

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.